Top Analyst Upgrades and Downgrades (AMAT, AZN, BSX, CCL, ENDP, JCG, KLAC, LRCX, LVS, MDT, MPEL, MGM, NVLS, PENN, DGX, TKC, WYNN)

Print Email

These are some of this Wednesday’s top analyst upgrades, downgrades, and initiations seen in Wall Street research notes:

Applied Materials Inc. (NASDAQ: AMAT) Started as Neutral at Susquehanna.
AstraZeneca plc (NYSE: AZN) Cut to Hold at RBS.
Boston Scientific Corp. (NYSE: BSX) Started as Hold at Jefferies.
Carnival Corporation (NYSE: CCL) Raised to Buy at Goldman Sachs.
Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP) Raised to Outperform at Oppenheimer.
J. Crew Group (NYSE: JCG) Cut to Neutral at Janney.
KLA-Tencor Corp. (NASDAQ: KLAC) Started as Positive at Susquehanna.
Lam Research Corp. (NASDAQ: LRCX) Started as Negative at Susquehanna.
Las Vegas Sands Corp. (NYSE: LVS) Started as Market Perform at Wells Fargo.
Medtronic, Inc. (NYSE: MDT) Started as Hold at Jefferies.
Melcro Crown Entertainment Ltd. (NASDAQ: MPEL) Started as Market Perform at Wells Fargo.
MGM Resorts International (NYSE: MGM) Started as Market Perform at Wells Fargo.
Novellus Systems, Inc. (NASDAQ: NVLS) Started as Neutral at Susquehanna.
Penn National Gaming (NASDAQ: PENN) Started as Outperform at Wells Fargo.
Quest Diagnostics Inc. (NYSE: DGX) Started as Buy at Kaufman Bros.
Turkcell Iletisim Hizmetleri AS (NYSE: TKC) Cut to Sell at UBS.
Wynn Resorts Ltd. (NASDAQ: WYNN) Started as Outperform at Wells Fargo.

You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.

JON C. OGG